BP000993-PKA-244: Recombinant Human VEGFR3
Source: Insect Cells-derived.
Measured by its ability to bind recombinant rat VEGF-C in a functional solid phase binding assay. Immobilised recombinant human VEGFR-3/FLT-4 at 5 ng/ml can bind recombinant rat VEGF-C in a linear range of 8-500 ng/ml.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000993-PKA-245: Recombinant Human VEGFR3 Fc Chimera
Source: Insect Cells-derived.
Measured by its ability to bind recombinant rat VEGF-C in a functional solid phase binding assay. Immobilised recombinant human VEGFR-3/FLT-4 at 5 ?/ml can bind recombinant rat VEGF-C in a linear range of 8-500 ng/ml.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP004312: Human VEGF R3/FLT4 Protein with the C-hFc Tag
Source: The recombinant Human VEGF R3/FLT4 Protein, (amino acids Tyr25-Ile776) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human VEGF-C protein with the C-hFc tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human VEGF R3 protein with the C-hFc tag with the EC50 of 17.9 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
BP005029: Human VEGF R3/FLT4 Protein with the C-His-Avi Tag
Source: The recombinant Human VEGF R3/FLT4 Protein, (amino acids Tyr25-Ile776) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: The affinity constant of 0.29 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.